Oncomark
OverviewSuggest Edit
OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to create unique multi-marker assays for use in the discrimination of patient response to drug therapies and apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level. This is of particular benefit to the pharmaceutical and health authority sectors.
| Type | Private | |
| Founded | 2007 | |
| HQ | Dublin 4, IE | Map |
| Website | oncomark.com |
Recent NewsAll News
- December 2019: OncoMasTR Clinical Validation Study Published in Peer-Reviewed Journal Clinical Cancer Research
- November 2019: OncoMark Founder Professor William Gallagher Receives the 2019 Science Foundation Ireland Entrepreneurship Award
- November 2019: OncoMark Founder Receives Award
- June 2019: OncoMark to present results from a key study at ASCO 2019
Latest Updates
| Employees (est.) (Apr 2022) | 5 | |
| Cybersecurity rating | A | More |
Key People/Management at Oncomark
Desmond OLeary
Stephen Penney
William Gallagher
Máirín Rafferty
Oncomark Office Locations
Oncomark Financials and Metrics
Summary Metrics
Founding Date | 2007 |
Oncomark total Funding | $4.9 m |
Oncomark latest funding size | $2.22 m |
Time since last funding | 5 years ago |
Oncomark investors | Enterprise Ireland, Irrus Investments, Kernel Capital, Horizon 2020, Bank of Ireland |
Oncomark Cybersecurity Score
Oncomark Online and Social Media Presence
326 Twitter followers
Oncomark has 326 Twitter Followers. The number of followers has increased 1.7% month over month and increased 2.7% quarter over quarter
Oncomark's Trends
Oncomark Blogs
December 2019: OncoMasTR Clinical Validation Study Published in Peer-Reviewed Journal Clinical Cancer Research
November 2019: OncoMark Founder Professor William Gallagher Receives the 2019 Science Foundation Ireland Entrepreneurship Award
November 2019: OncoMark Founder Receives Award
June 2019: OncoMark to present results from a key study at ASCO 2019
October 2018: OncoMark attending ESMO
August 2018 - OncoMasTR test CE marked
Oncomark Frequently Asked Questions
When was Oncomark founded?
Oncomark was founded in 2007.
Who are Oncomark key executives?
Oncomark's key executives are Desmond OLeary, Stephen Penney and William Gallagher.
How many employees does Oncomark have?
Oncomark has 5 employees.
Who are Oncomark competitors?
Competitors of Oncomark include Cipla, Alembic Pharmaceuticals and EMS Pharma.
Where is Oncomark headquarters?
Oncomark headquarters is located at NovaUCD, Innovation Park, UCD, Belfield, Dublin 4.
Where are Oncomark offices?
Oncomark has an office in Dublin 4.
How many offices does Oncomark have?
Oncomark has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies